I LIKE IT DO YOU ALSO LOVE IIT
The summary of the research - clinical outcomes and survival differences between primary, secondary and concomitants carcinoma in situ of urinary bladder treated with BCG Immunotherapy is given below.
<h3>What is the summary of the above research?</h3>
Urinary bladder carcinoma in situ (CIS) is a flat, high-grade, and aggressive form of urothelial cancer with a high likelihood of development to muscle-invasive illness and metastatic dissemination.
The study's goal was to compare the clinical histories and survival rates of primary, secondary, and concurrent CIS of the bladder.
Learn more about Immunotherapy at brainly.com/question/14493516
#SPJ1
Answer:
Here
Explanation:
To move keyboard to bottom of screen, you just need to tap and hold the keyboard icon at the bottom-right corner of the keyboard, choose Dock option. To fix iPad keyboard in middle of screen, please tap and hold the keyboard icon, then choose Dock.Nov 5, 2020
